Skip to content
Evigrade
CriticalClass III antiarrhythmic×First-generation antihistamine with anxiolytic activity

Updated · Methodology

Mechanism

Hydroxyzine has been associated with QT prolongation. Post-marketing reports describe QT prolongation and torsade de pointes, mostly in people with other risk factors, electrolyte disturbances and concomitant medicines (hydroxyzine summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Dronedarone, a class III antiarrhythmic, prolongs the heart-rate-corrected QT interval (QTc). According to the European SmPC, the increase is about 10 ms (Bazett). The US label estimates 15 ms at 400 mg twice daily with food (dronedarone SmPC, European Medicines Agency, EMA, and label, US Food and Drug Administration, FDA). The Spanish hydroxyzine SmPC links its contraindication with QT-prolonging drugs to a higher risk of arrhythmia. It separately asks for special caution with drugs that slow the heart rate or lower potassium. A slow heart rate is among the adverse reactions of dronedarone (hydroxyzine SmPC, AEMPS; dronedarone SmPC, EMA). Alcohol dehydrogenase and CYP3A4/5 metabolise hydroxyzine. The SmPC expects higher hydroxyzine levels with strong inhibitors of these enzymes, but if only one pathway is inhibited, the other may partly compensate (hydroxyzine SmPC, AEMPS). Dronedarone is a moderate CYP3A4 inhibitor, and the documents do not say how much it raises hydroxyzine levels (dronedarone SmPC, EMA).

Symptoms

QT prolongation itself causes no symptoms and shows only on an electrocardiogram (ECG), while an arrhythmia causes palpitations, dizziness and fainting. The adverse reactions of hydroxyzine include QT prolongation and ventricular arrhythmias, including torsade de pointes (hydroxyzine summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). The adverse reactions of dronedarone include a slow heart rate and QTc prolongation (dronedarone SmPC, European Medicines Agency, EMA). Dronedarone has a low proarrhythmic effect, but arrhythmias can occur when it is combined with drugs that favour arrhythmias or when electrolytes are disturbed (dronedarone SmPC, EMA).

Management

The combination is contraindicated under the Spanish hydroxyzine summary of product characteristics (SmPC). It contraindicates hydroxyzine with drugs that prolong the QT interval or induce torsade de pointes and lists class III antiarrhythmics among the examples. According to its own SmPC, dronedarone belongs to this class and prolongs the QT interval (hydroxyzine SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS; dronedarone SmPC, European Medicines Agency, EMA). The dronedarone documents in turn contraindicate dronedarone with drugs that prolong the QT interval and can induce torsade de pointes. Hydroxyzine is not among their examples. The contraindication still covers it, because the hydroxyzine documents describe QT prolongation and cases of torsade de pointes (dronedarone SmPC, EMA, and label, US Food and Drug Administration, FDA; hydroxyzine SmPC, AEMPS, and label, FDA). The US hydroxyzine label recommends caution with class III antiarrhythmics and is less strict than the Spanish SmPC (hydroxyzine label, FDA). Hydroxyzine is also contraindicated in known QT prolongation, cardiovascular disease, low potassium or magnesium, a family history of sudden cardiac death and significant bradycardia (hydroxyzine SmPC, AEMPS). Dronedarone is contraindicated in current or past heart failure, a heart rate below 50 beats per minute and a Bazett-corrected QT interval (QTc) of 500 ms or more (dronedarone SmPC, EMA). Correct potassium and magnesium deficiency before and during dronedarone treatment. During treatment, the SmPC recommends monitoring that includes an electrocardiogram (ECG). Stop dronedarone if the QTc reaches 500 ms or more (dronedarone SmPC, EMA). Use hydroxyzine at the lowest effective dose for the shortest possible time. If hydroxyzine and dronedarone have nevertheless been taken together and signs of arrhythmia appear, stop hydroxyzine (hydroxyzine SmPC, AEMPS). No document gives an interval between stopping one drug and starting the other. Dronedarone and its metabolite are fully cleared from plasma 2 weeks after dronedarone is stopped. The half-life of hydroxyzine is about 14 hours in adults and up to 29 hours in older people (dronedarone SmPC, EMA; hydroxyzine SmPC, AEMPS).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Dronedarone

Other interactions with Hydroxyzine